Controversies and opportunities in economic analysis of health care

Editorial

William S Weintraub. Circ Cardiovasc Qual Outcomes. 2009 Sep.

. 2009 Sep;2(5):402-3.

doi: 10.1161/CIRCOUTCOMES.109.901850.

No abstract available

Comment on

Cost-effectiveness of therapeutic hypothermia after cardiac arrest.
Merchant RM, Becker LB, Abella BS, Asch DA, Groeneveld PW. Merchant RM, et al. Circ Cardiovasc Qual Outcomes. 2009 Sep;2(5):421-8. doi: 10.1161/CIRCOUTCOMES.108.839605. Epub 2009 Aug 4. Circ Cardiovasc Qual Outcomes. 2009. PMID: 20031872
Cost-effectiveness of genotype-guided warfarin dosing for patients with atrial fibrillation.
Patrick AR, Avorn J, Choudhry NK. Patrick AR, et al. Circ Cardiovasc Qual Outcomes. 2009 Sep;2(5):429-36. doi: 10.1161/CIRCOUTCOMES.108.808592. Epub 2009 Jul 21. Circ Cardiovasc Qual Outcomes. 2009. PMID: 20031873
Impact of restrictive prescription plans on heart failure medication use.
Thanassoulis G, Karp I, Humphries K, Tu JV, Eisenberg MJ, Pilote L. Thanassoulis G, et al. Circ Cardiovasc Qual Outcomes. 2009 Sep;2(5):484-90. doi: 10.1161/CIRCOUTCOMES.108.804351. Epub 2009 Sep 1. Circ Cardiovasc Qual Outcomes. 2009. PMID: 20031881
Patients as mercenaries?: the ethics of using financial incentives in the war on unhealthy behaviors.
Halpern SD, Madison KM, Volpp KG. Halpern SD, et al. Circ Cardiovasc Qual Outcomes. 2009 Sep;2(5):514-6. doi: 10.1161/CIRCOUTCOMES.109.871855. Circ Cardiovasc Qual Outcomes. 2009. PMID: 20031885 Free PMC article. No abstract available.